Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation
- Creator: Joshi, Maansi , Taper, John , Huang, Gillian , Hertzberg, Mark , Forsyth, Cecily , Rowlings, Philip , Campbell, Philip , Crispin, Philip , Harvey, Michael , Underhill, Craig , Bayley, Angela , Byth, Karen
- Resource Type: journal article
- Date: 2020
A prospective, multicenter study of involved-field radiation therapy with autologous stem cell transplantation for patients with hodgkin lymphoma and aggressive non-hodgkin lymphoma (ALLG HDNHL04/TROG 03.03)
- Creator: Wirth, Andrew , Prince, H. Miles , Roos, Daniel , Gibson, John , O'Brien, Peter , Zannino, Diana , Khodr, Bereha , Stone, Janey M. , Davis, Sidney , Hertzberg, Mark
- Resource Type: journal article
- Date: 2019
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial
- Creator: Iland, Harry J. , Collins, Marnie , Hugman, Amanda , Reynolds, John , Di Iulio, Juliana , Tiley, Campbell , Taylor, Kerry , Filshie, Robin , Seldon, Michael , Taper, John , Szer, Jeff , Moore, John , Bradstock, Ken , Bashford, John , Seymour, John F. , Supple, Shane G. , Catalano, Alberto , Hertzberg, Mark , Browett, Peter , Grigg, Andrew , Firkin, Frank , Campbell, Lynda J.
- Resource Type: journal article
- Date: 2015
A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial
- Creator: Hertzberg, Mark , Matthews, Jane Palfrey , Abdi, Ehtesham , Green, Michael , Bonaventura, Anthony , Marlton, Paula , Cannell, Paul , Wolf, Max , Stone, Janey Malka , Dubosq, Ming-Celine , Grigg, Andrew , Ellis, David , Benson, Warwick , Browett, Peter , Horvath, Noemi , Januszewicz, Henry
- Resource Type: journal article
- Date: 2014
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
- Creator: Iland, Harry J. , Bradstock, Ken , Reynolds, John , Di Iulio, Juliana , Tiley, Campbell , Taylor, Kerry , Filshie, Robin , Seldon, Michael , Taper, John , Szer, Jeff , Moore, John , Bashford, John , Supple, Shane G. , Seymour, John F. , Catalano, Alberto , Collins, Marnie , Hertzberg, Mark , Browett, Peter , Grigg, Andrew , Firkin, Frank , Hugman, Amanda
- Resource Type: journal article
- Date: 2012
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy
- Creator: Hughes, Timothy P. , Branford, Susan , Cooney, Julian , Leahy, Michael F. , Rowlings, Philip , Catalano, John , Hertzberg, Mark , Filshie, Robin , Mills, Anthony K. , Fay, Keith , Durrant, Simon , Januszewicz, Henry , White, Deborah L. , Joske, David , Underhill, Craig , Dunkley, Scott , Lynch, Kevin , Grigg, Andrew , Reynolds, John , Koelmeyer, Rachel , Seymour, John F. , Taylor, Kerry , Arthur, Chris , Schwarer, Anthony K. , Morton, James
- Resource Type: journal article
- Date: 2008